Literature DB >> 3362929

Haloperidol and apomorphine effects on ethanol reinforcement in free feeding rats.

A O Pfeffer1, H H Samson.   

Abstract

Free feeding male Long Evans rats were trained to lever press on a Fixed Ratio 8 schedule for 10% ethanol reinforcement. Mean ethanol intake in 30-minute sessions was 0.38 g/kg. Subcutaneous apomorphine (APO: 0.025 to 0.5 mg/kg) and haloperidol (HAL: 0.005 to 0.0625 mg/kg) administered 15 minutes before sessions dose-dependently reduced responding, but only APO reduced momentary response rates. Low doses of HAL reduced the effect of 0.3 but not 0.05 mg/kg APO. When the rats were food-restricted, control response rates decreased, and APO (0.025 and 0.05 mg/kg) had no further effect. Results were discussed in terms of dopamine involvement in the mechanism of ethanol reinforcement.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3362929     DOI: 10.1016/0091-3057(88)90167-0

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  21 in total

1.  Effects of A₂A adenosine receptor blockade or stimulation on alcohol intake in alcohol-preferring rats.

Authors:  Maria Vittoria Micioni Di Bonaventura; Carlo Cifani; Catia Lambertucci; Rosaria Volpini; Gloria Cristalli; Rino Froldi; Maurizio Massi
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

2.  Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement.

Authors:  James R Shoblock; Natalie Welty; Leah Aluisio; Ian Fraser; S Timothy Motley; Kirsten Morton; James Palmer; Pascal Bonaventure; Nicholas I Carruthers; Timothy W Lovenberg; Jamin Boggs; Ruggero Galici
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

3.  Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide.

Authors:  F Weiss; M Mitchiner; F E Bloom; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Effects of dopaminergic agents on alcohol consumption by rats in a limited access paradigm.

Authors:  M A Linseman
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Motivational effects of ethanol in DARPP-32 knock-out mice.

Authors:  F O Risinger; P A Freeman; P Greengard; A A Fienberg
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

Review 6.  Ethanol action on dopaminergic neurons in the ventral tegmental area: interaction with intrinsic ion channels and neurotransmitter inputs.

Authors:  Hitoshi Morikawa; Richard A Morrisett
Journal:  Int Rev Neurobiol       Date:  2010       Impact factor: 3.230

7.  Prior Exposure to Alcohol Has No Effect on Cocaine Self-Administration and Relapse in Rats: Evidence from a Rat Model that Does Not Support the Gateway Hypothesis.

Authors:  Ida Fredriksson; Sweta Adhikary; Pia Steensland; Leandro F Vendruscolo; Antonello Bonci; Yavin Shaham; Jennifer M Bossert
Journal:  Neuropsychopharmacology       Date:  2016-09-21       Impact factor: 7.853

8.  Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat.

Authors:  Anne Marie D Axel; Jens D Mikkelsen; Henrik H Hansen
Journal:  Neuropsychopharmacology       Date:  2010-03-03       Impact factor: 7.853

9.  Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography.

Authors:  Erkki Tupala; Håkan Hall; Kim Bergström; Tuija Mantere; Pirkko Räsänen; Terttu Särkioja; Jari Tiihonen
Journal:  Hum Brain Mapp       Date:  2003-10       Impact factor: 5.038

10.  Nicotinic acetylcholine receptors containing α6 subunits contribute to alcohol reward-related behaviours.

Authors:  M S Powers; H J Broderick; R M Drenan; J A Chester
Journal:  Genes Brain Behav       Date:  2013-05-07       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.